Hawkins Nicholas B. 4
4 · Arteris, Inc. · Filed May 15, 2026
Research Summary
AI-generated summary of this filing
Arteris (AIP) CFO Nicholas Hawkins Sells Shares & Exercises Options
What Happened
Nicholas B. Hawkins, Chief Financial Officer of Arteris, exercised stock options and sold common shares on May 15, 2026. He exercised 197,396 option shares at $0.56 (cost $110,542) and 15,625 option shares at $9.28 (cost $145,000), for a total of 213,021 shares acquired via exercise. On the same day he disposed of 221,035 shares in open-market transactions, generating gross proceeds of approximately $7,381,778 (sales reported as three blocks: 52,928 @ $32.97, 164,916 @ $33.51, and 3,191 @ $34.59). The filing also shows corresponding derivative “disposed” entries at $0.00 for the exercised option amounts (common when shares are withheld to cover exercise cost or tax withholding).
Key Details
- Transaction date: May 15, 2026. Filing date / Period of Report: May 15, 2026 (timely filed).
- Options exercised: 197,396 @ $0.56 = $110,542; 15,625 @ $9.28 = $145,000 (total cash paid for exercise $255,542).
- Shares sold (open market): 52,928 @ $32.97 = $1,745,296 (F1), 164,916 @ $33.51 = $5,526,121 (F2), 3,191 @ $34.59 = $110,361 (F3). Total gross proceeds ≈ $7,381,778.
- Footnotes: F1–F3 note the reported sale prices are weighted averages; actual sale prices in each block ranged across the listed price bands (F1: $32.18–$33.175; F2: $33.18–$33.98; F3: $34.42–$34.65). The reporting person will provide full breakdowns on request.
- Vesting/option details: F4 = incentive stock options vesting schedule (initial 25% vesting 11/11/2020, remainder monthly over 3 years); F5 = non‑qualified stock options vesting quarterly starting 4/1/2025.
- Shares owned after the transactions: not specified in the provided filing excerpt.
Context
- This filing shows an option exercise combined with same‑day open‑market sales. The $0.00 "disposed" entries typically reflect shares withheld or surrendered in connection with the exercise (e.g., to satisfy exercise price or tax withholding) rather than a separate cash sale.
- Sales by insiders are often routine (liquidity or tax events); the filing is factual and does not indicate the insider’s motivation.
Insider Transaction Report
Form 4
Hawkins Nicholas B.
VP and Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2026-05-15$0.56/sh+197,396$110,542→ 316,010 total - Exercise/Conversion
Common Stock
2026-05-15$9.28/sh+15,625$145,000→ 331,635 total - Sale
Common Stock
[F1]2026-05-15$32.97/sh−52,928$1,745,296→ 278,707 total - Sale
Common Stock
[F2]2026-05-15$33.51/sh−164,916$5,526,121→ 113,791 total - Sale
Common Stock
[F3]2026-05-15$34.59/sh−3,191$110,361→ 110,600 total - Exercise/Conversion
Incentive Stock Option (right to buy)
[F4]2026-05-15−197,396→ 0 totalExercise: $0.56Exp: 2029-12-18→ Common Stock (197,396 underlying) - Exercise/Conversion
Non-Qualified Stock Option (right to buy)
[F5]2026-05-15−15,625→ 0 totalExercise: $9.28Exp: 2035-02-20→ Common Stock (15,625 underlying)
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $32.18 to $33.175 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F2]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $33.18 to $33.98 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $34.42 to $34.65 inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]Incentive stock options, 25% of the total shares vested on November 11, 2020 and the remainder vesting 1/48th monthly thereafter for three years.
- [F5]Non-qualified stock options, vesting in 16 equal quarterly installments of 1/16th each, beginning on April 1, 2025.
Signature
/s/ Paul Alpern, as Attorney-in-Fact for Hawkins Nicholas B.|2026-05-15